SCHEDULE: FMR LLC Discloses 11.9% Stake in Climb Bio Inc.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 11.9% in Climb Bio Inc. as of June 30, 2026.

Summary

• FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, indicating their beneficial ownership of Climb Bio Inc. common stock.
• The filing, dated June 30, 2026, shows a combined beneficial ownership of 6,790,364 shares.
• This represents 11.9% of the total outstanding shares of Climb Bio Inc.'s common stock.
• FMR LLC is identified as a holding company (HC), and Abigail P. Johnson is identified as an investment advisor (IA).
• The filing confirms that no single other person's interest in Climb Bio Inc. exceeds five percent of the total outstanding common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It indicates significant institutional ownership but provides no new operational or financial information about Climb Bio Inc. itself.

Positives

• Significant institutional ownership by FMR LLC and Abigail P. Johnson, indicating confidence in Climb Bio Inc.
• Clear disclosure of beneficial ownership, providing transparency to the market.

Negatives

• The filing does not contain specific financial performance data for Climb Bio Inc., making it difficult to assess the company's operational health.
• The nature of the filing (Schedule 13G) suggests a passive investment rather than active control, which may limit immediate strategic impact.

Risks

• The filing does not explicitly mention any risks associated with Climb Bio Inc.'s business operations or the investment itself.
• Potential for future changes in beneficial ownership by FMR LLC or Abigail P. Johnson could impact the stock.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Climb Bio Inc.'s future performance.

Management Comments

• FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by FMR LLC and Abigail P. Johnson indicates a significant passive investment in Climb Bio Inc., a company likely operating in the biotechnology or life sciences sector, given its name. Such filings often signal sustained institutional interest, though not necessarily active engagement in management.

Stakeholder Impact

• Shareholders: Increased institutional ownership may be viewed positively, potentially leading to greater stability or future strategic alignment, but the passive nature of the filing offers no immediate operational impact.
• Management of Climb Bio Inc.: May need to consider the interests of a significant institutional holder, although the passive filing suggests no immediate pressure for control changes.
• Potential Investors: The filing provides transparency on a major shareholder, which can be a factor in investment decisions.

Next Steps

• Monitor future filings by FMR LLC and Abigail P. Johnson for any changes in their beneficial ownership of Climb Bio Inc.
• Observe Climb Bio Inc.'s subsequent disclosures for any strategic implications arising from this significant ownership stake.

Key Dates

Keywords

Climb Bio Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing